Clinical Trial Update: Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide with or without pomalidomide in combination with dexamethasone for multiple myeloma; the study was terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Smoldering Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2025-08-20